Viking Therapeutics Statistics

Total Valuation

FRA:1VT has a market cap or net worth of EUR 3.59 billion. The enterprise value is 2.97 billion.

Market Cap	3.59B
Enterprise Value	2.97B

Important Dates

The next estimated earnings date is Thursday, February 5, 2026.

Earnings Date	Feb 5, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	113.04M
Shares Outstanding	n/a
Shares Change (YoY)	+5.48%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	2.17%
Owned by Institutions (%)	65.49%
Float	110.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	5.90
P/TBV Ratio	5.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-14.69
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 28.34, with a Debt / Equity ratio of 0.00.

Current Ratio	28.34
Quick Ratio	27.41
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3,435.53

Financial Efficiency

Return on equity (ROE) is -29.23% and return on invested capital (ROIC) is -21.12%.

Return on Equity (ROE)	-29.23%
Return on Assets (ROA)	-20.48%
Return on Invested Capital (ROIC)	-21.12%
Return on Capital Employed (ROCE)	-38.53%
Revenue Per Employee	n/a
Profits Per Employee	-3.97M
Employee Count	36
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.02% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-38.02%
50-Day Moving Average	29.16
200-Day Moving Average	25.89
Relative Strength Index (RSI)	52.60
Average Volume (20 Days)	495

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.28

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-234.25M
Pretax Income	-202.33M
Net Income	-202.33M
EBITDA	n/a
EBIT	-234.25M
Earnings Per Share (EPS)	-1.81

Full Income Statement

Balance Sheet

The company has 609.03 million in cash and 643,487 in debt, giving a net cash position of 608.38 million.

Cash & Cash Equivalents	609.03M
Total Debt	643,487
Net Cash	608.38M
Net Cash Per Share	n/a
Equity (Book Value)	607.72M
Book Value Per Share	5.40
Working Capital	607.38M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-191.41M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:1VT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.48%
Shareholder Yield	-5.48%
Earnings Yield	-5.64%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1